U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07433387) titled 'Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals' on Feb. 05.
Brief Summary: An Exploratory Multicenter, Open-label, Sequential Cohort Study to Evaluate the Preliminary Efficacy, Safety, and Pharmacokinetic Characteristics of LP-98 for Injection in Antiretroviral Therapy-Naive HIV-Infected Individuals
Study Start Date: Jan. 29
Study Type: INTERVENTIONAL
Condition:
HIV
Intervention:
DRUG: LP-98 20 mg
The study plans to enroll a total of 30 subjects, with 10 subjects in each cohort. Enrolled subjects will receive LP-98 treatment at doses of 20 mg, 40 mg, or 80 mg according to their assigned cohort....